| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Swine | 156 | 2024 | 1158 | 8.300 |
Why?
|
| Animals, Newborn | 102 | 2024 | 1007 | 6.760 |
Why?
|
| Intestinal Mucosa | 64 | 2021 | 774 | 5.180 |
Why?
|
| Bile Acids and Salts | 18 | 2023 | 237 | 4.860 |
Why?
|
| Enteral Nutrition | 34 | 2023 | 248 | 4.360 |
Why?
|
| Intestines | 43 | 2023 | 580 | 4.270 |
Why?
|
| Parenteral Nutrition | 19 | 2022 | 186 | 3.780 |
Why?
|
| Fat Emulsions, Intravenous | 8 | 2021 | 71 | 3.560 |
Why?
|
| Parenteral Nutrition, Total | 23 | 2014 | 117 | 3.340 |
Why?
|
| Enterocolitis, Necrotizing | 20 | 2023 | 237 | 3.200 |
Why?
|
| Infant, Premature | 23 | 2023 | 800 | 2.920 |
Why?
|
| Protein Biosynthesis | 40 | 2022 | 668 | 2.610 |
Why?
|
| Liver Diseases | 7 | 2023 | 384 | 2.570 |
Why?
|
| Glucagon-Like Peptide 2 | 27 | 2019 | 54 | 2.540 |
Why?
|
| Intestine, Small | 23 | 2019 | 313 | 2.500 |
Why?
|
| Cholestasis | 8 | 2022 | 161 | 2.460 |
Why?
|
| Amino Acids | 42 | 2023 | 661 | 2.400 |
Why?
|
| Colostrum | 20 | 2021 | 54 | 2.400 |
Why?
|
| Intestinal Absorption | 25 | 2019 | 191 | 2.380 |
Why?
|
| Fibroblast Growth Factors | 9 | 2023 | 155 | 2.350 |
Why?
|
| Animals | 200 | 2024 | 33923 | 2.310 |
Why?
|
| Liver | 33 | 2023 | 1858 | 2.130 |
Why?
|
| Soybean Oil | 9 | 2021 | 65 | 2.040 |
Why?
|
| Premature Birth | 18 | 2023 | 380 | 2.000 |
Why?
|
| Sus scrofa | 12 | 2020 | 122 | 1.960 |
Why?
|
| Glutamic Acid | 16 | 2013 | 200 | 1.800 |
Why?
|
| Phytosterols | 5 | 2021 | 27 | 1.750 |
Why?
|
| Arginine | 8 | 2024 | 303 | 1.700 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 7 | 2022 | 392 | 1.670 |
Why?
|
| Citrulline | 6 | 2024 | 84 | 1.600 |
Why?
|
| Insulin-Like Growth Factor I | 18 | 2023 | 339 | 1.530 |
Why?
|
| Infant Nutritional Physiological Phenomena | 8 | 2021 | 191 | 1.510 |
Why?
|
| Peptides | 12 | 2014 | 799 | 1.450 |
Why?
|
| Short Bowel Syndrome | 8 | 2020 | 60 | 1.390 |
Why?
|
| Disease Models, Animal | 20 | 2024 | 4308 | 1.380 |
Why?
|
| Milk, Human | 7 | 2023 | 295 | 1.310 |
Why?
|
| Gastrointestinal Tract | 10 | 2023 | 208 | 1.300 |
Why?
|
| Dietary Supplements | 9 | 2023 | 462 | 1.290 |
Why?
|
| Phospholipids | 3 | 2019 | 107 | 1.270 |
Why?
|
| Dietary Proteins | 13 | 2018 | 239 | 1.260 |
Why?
|
| Vitamin E | 3 | 2019 | 64 | 1.260 |
Why?
|
| Fish Oils | 7 | 2021 | 82 | 1.250 |
Why?
|
| Infant, Newborn | 35 | 2023 | 8120 | 1.210 |
Why?
|
| Digestive System | 11 | 2003 | 60 | 1.200 |
Why?
|
| Amino Acids, Sulfur | 4 | 2009 | 15 | 1.200 |
Why?
|
| Gastrointestinal Microbiome | 8 | 2023 | 678 | 1.180 |
Why?
|
| Methionine | 6 | 2011 | 102 | 1.150 |
Why?
|
| Homeostasis | 7 | 2022 | 682 | 1.140 |
Why?
|
| Swine Diseases | 4 | 2020 | 36 | 1.110 |
Why?
|
| Ileum | 6 | 2020 | 134 | 1.100 |
Why?
|
| Lipid Metabolism | 3 | 2022 | 354 | 1.050 |
Why?
|
| Glucagon-Like Peptides | 13 | 2011 | 34 | 1.050 |
Why?
|
| Jejunum | 15 | 2020 | 128 | 0.990 |
Why?
|
| Triglycerides | 7 | 2021 | 560 | 0.980 |
Why?
|
| Glucose | 14 | 2024 | 876 | 0.940 |
Why?
|
| Animal Feed | 10 | 2020 | 76 | 0.930 |
Why?
|
| Lactose | 4 | 2018 | 54 | 0.920 |
Why?
|
| Models, Animal | 11 | 2022 | 467 | 0.910 |
Why?
|
| Endotoxemia | 1 | 2024 | 57 | 0.900 |
Why?
|
| Animal Nutritional Physiological Phenomena | 14 | 2021 | 61 | 0.880 |
Why?
|
| Muscle, Skeletal | 21 | 2023 | 936 | 0.880 |
Why?
|
| beta Carotene | 1 | 2023 | 41 | 0.860 |
Why?
|
| Polyethylene Glycols | 1 | 2024 | 217 | 0.850 |
Why?
|
| Signal Transduction | 15 | 2022 | 4524 | 0.850 |
Why?
|
| Probiotics | 5 | 2023 | 209 | 0.840 |
Why?
|
| Organ Size | 21 | 2023 | 415 | 0.830 |
Why?
|
| Docosahexaenoic Acids | 3 | 2019 | 66 | 0.830 |
Why?
|
| High Fructose Corn Syrup | 2 | 2021 | 7 | 0.810 |
Why?
|
| Hydrocortisone | 2 | 2022 | 215 | 0.810 |
Why?
|
| Cesarean Section | 4 | 2021 | 380 | 0.810 |
Why?
|
| Parturition | 1 | 2022 | 62 | 0.800 |
Why?
|
| Splanchnic Circulation | 8 | 2014 | 53 | 0.800 |
Why?
|
| Inflammation | 7 | 2024 | 1401 | 0.780 |
Why?
|
| Diet | 19 | 2020 | 1112 | 0.770 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 6 | 2022 | 389 | 0.760 |
Why?
|
| Pregnancy | 31 | 2023 | 7126 | 0.730 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2013 | 303 | 0.710 |
Why?
|
| Food, Formulated | 6 | 2020 | 51 | 0.700 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2021 | 170 | 0.690 |
Why?
|
| Colitis | 2 | 2012 | 156 | 0.690 |
Why?
|
| Female | 88 | 2024 | 65361 | 0.680 |
Why?
|
| Growth Hormone | 7 | 2004 | 151 | 0.680 |
Why?
|
| Dietary Fats | 2 | 2022 | 288 | 0.680 |
Why?
|
| Nutritional Physiological Phenomena | 11 | 2019 | 89 | 0.680 |
Why?
|
| Adaptation, Physiological | 10 | 2019 | 265 | 0.670 |
Why?
|
| Nitric Oxide | 4 | 2018 | 439 | 0.660 |
Why?
|
| Milk | 9 | 2020 | 118 | 0.660 |
Why?
|
| Epithelial Cells | 5 | 2013 | 907 | 0.660 |
Why?
|
| Glutamine | 7 | 2012 | 195 | 0.650 |
Why?
|
| Random Allocation | 13 | 2021 | 417 | 0.640 |
Why?
|
| Receptors, Glucagon | 7 | 2017 | 29 | 0.630 |
Why?
|
| Rifampin | 1 | 2019 | 145 | 0.630 |
Why?
|
| Cattle | 11 | 2021 | 559 | 0.630 |
Why?
|
| Insulin | 18 | 2024 | 1196 | 0.630 |
Why?
|
| Lactase | 8 | 2009 | 41 | 0.620 |
Why?
|
| Clostridium | 1 | 2018 | 16 | 0.620 |
Why?
|
| Gammaproteobacteria | 1 | 2018 | 16 | 0.620 |
Why?
|
| Bacillus | 1 | 2018 | 33 | 0.610 |
Why?
|
| Kidney | 8 | 2019 | 1346 | 0.600 |
Why?
|
| Homocysteine | 5 | 2011 | 121 | 0.590 |
Why?
|
| Kupffer Cells | 1 | 2017 | 21 | 0.590 |
Why?
|
| Endotoxins | 1 | 2017 | 50 | 0.590 |
Why?
|
| Cholestasis, Intrahepatic | 2 | 2019 | 67 | 0.580 |
Why?
|
| Lipopolysaccharides | 4 | 2024 | 292 | 0.580 |
Why?
|
| Dietary Carbohydrates | 1 | 2018 | 115 | 0.580 |
Why?
|
| Gastrointestinal Diseases | 3 | 2017 | 337 | 0.580 |
Why?
|
| Emulsions | 5 | 2021 | 65 | 0.580 |
Why?
|
| Humans | 76 | 2023 | 122971 | 0.570 |
Why?
|
| Microbiota | 2 | 2020 | 392 | 0.570 |
Why?
|
| Proteins | 16 | 2006 | 1045 | 0.570 |
Why?
|
| Infant, Premature, Diseases | 3 | 2014 | 239 | 0.560 |
Why?
|
| Food | 1 | 2017 | 119 | 0.540 |
Why?
|
| Hepatocytes | 2 | 2017 | 257 | 0.540 |
Why?
|
| Infant Formula | 6 | 2023 | 98 | 0.530 |
Why?
|
| Insulin Resistance | 5 | 2021 | 635 | 0.530 |
Why?
|
| Phenylalanine | 12 | 2005 | 122 | 0.520 |
Why?
|
| Digestion | 4 | 2017 | 37 | 0.510 |
Why?
|
| Sodium Glutamate | 2 | 2013 | 6 | 0.510 |
Why?
|
| Fatty Acids | 5 | 2022 | 339 | 0.510 |
Why?
|
| Body Weight | 17 | 2023 | 966 | 0.500 |
Why?
|
| Gastric Emptying | 2 | 2013 | 78 | 0.500 |
Why?
|
| Nutritional Support | 3 | 2020 | 51 | 0.490 |
Why?
|
| Eating | 10 | 2019 | 355 | 0.490 |
Why?
|
| Ketoglutaric Acids | 2 | 2006 | 24 | 0.490 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2011 | 95 | 0.470 |
Why?
|
| Lactase-Phlorizin Hydrolase | 8 | 2002 | 21 | 0.470 |
Why?
|
| Fatty Liver | 3 | 2012 | 182 | 0.470 |
Why?
|
| Muscle Proteins | 10 | 2022 | 416 | 0.460 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 1216 | 0.450 |
Why?
|
| Gestational Age | 9 | 2022 | 1119 | 0.450 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 3 | 2021 | 36 | 0.440 |
Why?
|
| Nitrogen | 7 | 2018 | 135 | 0.440 |
Why?
|
| Amino Acids, Essential | 5 | 2018 | 26 | 0.430 |
Why?
|
| Weight Gain | 15 | 2019 | 383 | 0.430 |
Why?
|
| Viscera | 10 | 2012 | 55 | 0.430 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2014 | 69 | 0.420 |
Why?
|
| Gastric Mucosa | 4 | 2009 | 483 | 0.420 |
Why?
|
| Animals, Domestic | 3 | 2017 | 30 | 0.420 |
Why?
|
| Mesenteric Artery, Superior | 3 | 2014 | 35 | 0.410 |
Why?
|
| Cell Survival | 3 | 2010 | 817 | 0.410 |
Why?
|
| Thionucleosides | 1 | 2012 | 5 | 0.410 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2014 | 1689 | 0.410 |
Why?
|
| Gene Expression | 6 | 2014 | 1592 | 0.400 |
Why?
|
| Blood Glucose | 19 | 2019 | 1108 | 0.400 |
Why?
|
| Nutritional Requirements | 4 | 2020 | 173 | 0.400 |
Why?
|
| Glucagon-Like Peptide 1 | 4 | 2017 | 68 | 0.400 |
Why?
|
| Animals, Suckling | 7 | 2003 | 50 | 0.390 |
Why?
|
| Cells, Cultured | 7 | 2017 | 3075 | 0.390 |
Why?
|
| Vitamin B 6 Deficiency | 1 | 2011 | 5 | 0.380 |
Why?
|
| Adenosine | 1 | 2012 | 126 | 0.380 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2022 | 428 | 0.370 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2011 | 39 | 0.370 |
Why?
|
| Oxidation-Reduction | 11 | 2012 | 444 | 0.370 |
Why?
|
| Metabolic Diseases | 1 | 2012 | 130 | 0.360 |
Why?
|
| Cell Division | 7 | 2009 | 793 | 0.360 |
Why?
|
| Sheep | 4 | 1992 | 211 | 0.350 |
Why?
|
| Isotope Labeling | 4 | 2009 | 102 | 0.350 |
Why?
|
| Hepatitis | 1 | 2010 | 65 | 0.350 |
Why?
|
| Leucine | 12 | 2023 | 309 | 0.340 |
Why?
|
| Up-Regulation | 4 | 2020 | 874 | 0.340 |
Why?
|
| Brain | 10 | 2023 | 2961 | 0.340 |
Why?
|
| Pancreas | 6 | 2019 | 214 | 0.340 |
Why?
|
| Proline | 2 | 2012 | 72 | 0.330 |
Why?
|
| Milk Proteins | 2 | 2021 | 91 | 0.330 |
Why?
|
| Portal System | 10 | 2007 | 33 | 0.330 |
Why?
|
| Oxidative Stress | 2 | 2014 | 804 | 0.320 |
Why?
|
| Spectroscopy, Near-Infrared | 3 | 2015 | 133 | 0.310 |
Why?
|
| Microvilli | 7 | 2013 | 73 | 0.310 |
Why?
|
| Food, Fortified | 3 | 2018 | 96 | 0.300 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 672 | 0.300 |
Why?
|
| Kinetics | 13 | 2012 | 1316 | 0.300 |
Why?
|
| Tritium | 10 | 2009 | 174 | 0.290 |
Why?
|
| Hyperbilirubinemia | 2 | 2019 | 43 | 0.290 |
Why?
|
| Bacterial Infections | 2 | 2021 | 305 | 0.280 |
Why?
|
| Male | 39 | 2024 | 59957 | 0.280 |
Why?
|
| Carbon Isotopes | 11 | 2012 | 272 | 0.270 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2022 | 284 | 0.270 |
Why?
|
| Apoptosis | 5 | 2006 | 1792 | 0.270 |
Why?
|
| Oxygen Consumption | 7 | 2011 | 304 | 0.270 |
Why?
|
| Colon | 4 | 2020 | 355 | 0.270 |
Why?
|
| RNA, Messenger | 11 | 2019 | 2833 | 0.270 |
Why?
|
| Organoids | 2 | 2021 | 275 | 0.260 |
Why?
|
| Plant Oils | 3 | 2018 | 32 | 0.260 |
Why?
|
| Carbon Dioxide | 6 | 2013 | 274 | 0.260 |
Why?
|
| Sucrase | 5 | 2017 | 22 | 0.260 |
Why?
|
| Hexoses | 1 | 2005 | 11 | 0.260 |
Why?
|
| Diet, High-Fat | 3 | 2022 | 207 | 0.260 |
Why?
|
| Galactose | 3 | 2009 | 55 | 0.260 |
Why?
|
| Spleen | 3 | 2006 | 287 | 0.250 |
Why?
|
| Analysis of Variance | 6 | 2011 | 1006 | 0.250 |
Why?
|
| Gastrointestinal Agents | 2 | 2017 | 61 | 0.250 |
Why?
|
| Malabsorption Syndromes | 1 | 2005 | 38 | 0.250 |
Why?
|
| Peroxidase | 3 | 2012 | 61 | 0.250 |
Why?
|
| Portal Vein | 7 | 2012 | 92 | 0.250 |
Why?
|
| Norovirus | 2 | 2021 | 303 | 0.250 |
Why?
|
| Nutritional Status | 5 | 2020 | 298 | 0.240 |
Why?
|
| Intestine, Large | 2 | 2001 | 16 | 0.240 |
Why?
|
| Cytokines | 4 | 2024 | 1287 | 0.240 |
Why?
|
| Proglucagon | 2 | 2017 | 5 | 0.240 |
Why?
|
| Glycoproteins | 3 | 2021 | 372 | 0.240 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2020 | 1007 | 0.230 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 2004 | 6 | 0.230 |
Why?
|
| Blood Proteins | 4 | 2000 | 116 | 0.230 |
Why?
|
| DNA | 9 | 2005 | 1608 | 0.230 |
Why?
|
| Fructose | 2 | 2021 | 59 | 0.230 |
Why?
|
| Growth Substances | 2 | 2002 | 113 | 0.230 |
Why?
|
| Hydrolases | 1 | 2024 | 85 | 0.230 |
Why?
|
| Infant Food | 4 | 2007 | 82 | 0.230 |
Why?
|
| Energy Metabolism | 9 | 2021 | 748 | 0.230 |
Why?
|
| Nitric Oxide Synthase Type III | 3 | 2010 | 221 | 0.230 |
Why?
|
| Blotting, Western | 4 | 2014 | 1106 | 0.230 |
Why?
|
| Obstetric Labor, Premature | 2 | 2013 | 85 | 0.220 |
Why?
|
| Zeaxanthins | 1 | 2023 | 9 | 0.220 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 3 | 1999 | 31 | 0.220 |
Why?
|
| Lutein | 1 | 2023 | 15 | 0.220 |
Why?
|
| Time Factors | 14 | 2013 | 6216 | 0.220 |
Why?
|
| Symporters | 1 | 2004 | 66 | 0.220 |
Why?
|
| Muscles | 4 | 1996 | 289 | 0.220 |
Why?
|
| Intestinal Diseases | 2 | 2021 | 83 | 0.220 |
Why?
|
| Bifidobacterium longum subspecies infantis | 1 | 2023 | 5 | 0.220 |
Why?
|
| Growth | 4 | 2014 | 107 | 0.220 |
Why?
|
| Vitamin A | 1 | 2023 | 61 | 0.220 |
Why?
|
| Sulfates | 2 | 2022 | 34 | 0.220 |
Why?
|
| Regional Blood Flow | 5 | 2012 | 213 | 0.220 |
Why?
|
| Infant | 9 | 2023 | 12355 | 0.220 |
Why?
|
| Swine, Miniature | 5 | 2016 | 47 | 0.210 |
Why?
|
| Sodium-Glucose Transporter 1 | 3 | 2010 | 11 | 0.210 |
Why?
|
| Carotenoids | 1 | 2023 | 75 | 0.210 |
Why?
|
| Immunity | 2 | 2020 | 183 | 0.210 |
Why?
|
| Cell Proliferation | 3 | 2019 | 2321 | 0.200 |
Why?
|
| Metabolomics | 2 | 2019 | 396 | 0.200 |
Why?
|
| Cysteine | 3 | 2009 | 134 | 0.200 |
Why?
|
| Endocrine System | 1 | 2022 | 21 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 1302 | 0.200 |
Why?
|
| Diet, Carbohydrate Loading | 1 | 2021 | 2 | 0.200 |
Why?
|
| Duodenum | 2 | 2020 | 99 | 0.200 |
Why?
|
| Abdomen | 2 | 2015 | 131 | 0.200 |
Why?
|
| Models, Biological | 8 | 2009 | 1440 | 0.200 |
Why?
|
| Incidence | 2 | 2023 | 3040 | 0.200 |
Why?
|
| Dextran Sulfate | 2 | 2012 | 48 | 0.200 |
Why?
|
| Myofibrils | 2 | 2001 | 27 | 0.190 |
Why?
|
| Embryonic and Fetal Development | 1 | 2001 | 135 | 0.190 |
Why?
|
| Biological Availability | 4 | 2012 | 128 | 0.190 |
Why?
|
| Glycolipids | 1 | 2021 | 33 | 0.190 |
Why?
|
| Threonine | 4 | 2012 | 60 | 0.190 |
Why?
|
| Disaccharidases | 2 | 1991 | 14 | 0.190 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2019 | 316 | 0.190 |
Why?
|
| Fetus | 2 | 2022 | 579 | 0.190 |
Why?
|
| Glutathione | 3 | 2011 | 198 | 0.190 |
Why?
|
| Oxylipins | 1 | 2021 | 4 | 0.190 |
Why?
|
| Stomach | 5 | 2009 | 273 | 0.190 |
Why?
|
| Dietary Sucrose | 1 | 2021 | 38 | 0.190 |
Why?
|
| Gastrointestinal Hormones | 1 | 2001 | 21 | 0.190 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2021 | 20 | 0.190 |
Why?
|
| Oligosaccharides | 1 | 2021 | 72 | 0.180 |
Why?
|
| Lipid Droplets | 1 | 2021 | 46 | 0.180 |
Why?
|
| Muscle Development | 5 | 2000 | 71 | 0.180 |
Why?
|
| Vagina | 1 | 2022 | 202 | 0.180 |
Why?
|
| Body Composition | 6 | 2023 | 479 | 0.180 |
Why?
|
| Feeding Methods | 1 | 2001 | 37 | 0.180 |
Why?
|
| Immunoglobulins | 1 | 2021 | 170 | 0.180 |
Why?
|
| Biomarkers | 3 | 2021 | 2952 | 0.180 |
Why?
|
| Oxygen | 3 | 2014 | 550 | 0.180 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2001 | 355 | 0.180 |
Why?
|
| Rats | 10 | 2014 | 3665 | 0.180 |
Why?
|
| Soybean Proteins | 1 | 2000 | 17 | 0.180 |
Why?
|
| Sucrase-Isomaltase Complex | 2 | 2017 | 19 | 0.180 |
Why?
|
| Cation Transport Proteins | 1 | 2001 | 99 | 0.180 |
Why?
|
| Lactalbumin | 1 | 2020 | 11 | 0.170 |
Why?
|
| Interleukin-1beta | 1 | 2021 | 160 | 0.170 |
Why?
|
| Protein-Energy Malnutrition | 3 | 1997 | 76 | 0.170 |
Why?
|
| Whey Proteins | 1 | 2020 | 6 | 0.170 |
Why?
|
| Chromatography, Liquid | 2 | 2022 | 189 | 0.170 |
Why?
|
| Aging | 6 | 2019 | 1175 | 0.170 |
Why?
|
| Choline | 1 | 2020 | 55 | 0.170 |
Why?
|
| Adiposity | 1 | 2021 | 183 | 0.170 |
Why?
|
| RNA, Transfer, Amino Acyl | 1 | 1999 | 5 | 0.170 |
Why?
|
| Growth Disorders | 1 | 2021 | 209 | 0.170 |
Why?
|
| Inactivation, Metabolic | 1 | 2019 | 33 | 0.170 |
Why?
|
| Progesterone | 1 | 2022 | 624 | 0.170 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2019 | 1193 | 0.170 |
Why?
|
| Immune System | 1 | 2020 | 86 | 0.160 |
Why?
|
| Placental Circulation | 1 | 2019 | 23 | 0.160 |
Why?
|
| Sitosterols | 1 | 2019 | 9 | 0.160 |
Why?
|
| Phosphorylation | 3 | 2010 | 1617 | 0.160 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2019 | 59 | 0.160 |
Why?
|
| Glucuronosyltransferase | 1 | 2019 | 70 | 0.160 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2022 | 227 | 0.160 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2019 | 80 | 0.160 |
Why?
|
| Urea | 4 | 2012 | 210 | 0.160 |
Why?
|
| Olive Oil | 2 | 2019 | 22 | 0.160 |
Why?
|
| beta-Galactosidase | 4 | 2001 | 157 | 0.160 |
Why?
|
| Infusions, Parenteral | 2 | 2021 | 100 | 0.150 |
Why?
|
| Metabolome | 1 | 2020 | 294 | 0.150 |
Why?
|
| Risk Factors | 6 | 2020 | 9950 | 0.150 |
Why?
|
| Fetal Blood | 1 | 2019 | 178 | 0.150 |
Why?
|
| Glucan 1,4-alpha-Glucosidase | 1 | 2017 | 5 | 0.150 |
Why?
|
| Glucagon-Like Peptide-2 Receptor | 4 | 2014 | 12 | 0.150 |
Why?
|
| Mice | 8 | 2017 | 17647 | 0.150 |
Why?
|
| Phenotype | 2 | 2024 | 4222 | 0.150 |
Why?
|
| Methylation | 2 | 2009 | 227 | 0.150 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 3 | 2023 | 163 | 0.140 |
Why?
|
| Neurodegenerative Diseases | 1 | 2020 | 251 | 0.140 |
Why?
|
| Starch | 1 | 2017 | 25 | 0.140 |
Why?
|
| Dexamethasone | 1 | 1999 | 274 | 0.140 |
Why?
|
| Virus Replication | 2 | 2021 | 603 | 0.140 |
Why?
|
| Fetal Diseases | 1 | 2021 | 443 | 0.140 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2017 | 37 | 0.140 |
Why?
|
| Administration, Oral | 5 | 2017 | 670 | 0.140 |
Why?
|
| alpha-Glucosidases | 5 | 2013 | 26 | 0.140 |
Why?
|
| Micelles | 1 | 2017 | 19 | 0.140 |
Why?
|
| Fetal Development | 1 | 2018 | 111 | 0.140 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2017 | 16 | 0.140 |
Why?
|
| Serum Amyloid A Protein | 2 | 2015 | 29 | 0.140 |
Why?
|
| Organ Culture Techniques | 1 | 2017 | 155 | 0.140 |
Why?
|
| Infusions, Intravenous | 5 | 2014 | 539 | 0.140 |
Why?
|
| Food Deprivation | 2 | 2008 | 29 | 0.140 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 374 | 0.140 |
Why?
|
| Palmitic Acid | 1 | 2016 | 35 | 0.140 |
Why?
|
| Atrophy | 4 | 2014 | 226 | 0.140 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2016 | 33 | 0.130 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2016 | 10 | 0.130 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2016 | 7 | 0.130 |
Why?
|
| Meta-Analysis as Topic | 1 | 2017 | 152 | 0.130 |
Why?
|
| Virus Cultivation | 1 | 2016 | 76 | 0.130 |
Why?
|
| Digestive System Physiological Phenomena | 3 | 2002 | 10 | 0.130 |
Why?
|
| Malnutrition | 1 | 2019 | 196 | 0.130 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 184 | 0.130 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 3 | 2017 | 65 | 0.130 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 78 | 0.130 |
Why?
|
| Neurons | 4 | 2017 | 1933 | 0.130 |
Why?
|
| Glucocorticoids | 1 | 1999 | 379 | 0.130 |
Why?
|
| Lipids | 2 | 2022 | 512 | 0.130 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2016 | 54 | 0.130 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2017 | 106 | 0.130 |
Why?
|
| Lactoferrin | 1 | 1996 | 77 | 0.130 |
Why?
|
| Enzyme Precursors | 4 | 2004 | 22 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2013 | 492 | 0.130 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2006 | 65 | 0.130 |
Why?
|
| Bottle Feeding | 1 | 2015 | 36 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 3 | 2012 | 4392 | 0.120 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2015 | 29 | 0.120 |
Why?
|
| Placenta | 1 | 2019 | 496 | 0.120 |
Why?
|
| Transplantation, Homologous | 1 | 2017 | 660 | 0.120 |
Why?
|
| Drug Administration Routes | 1 | 2014 | 30 | 0.120 |
Why?
|
| Transplantation Conditioning | 1 | 2017 | 323 | 0.120 |
Why?
|
| Mucin-2 | 2 | 2012 | 35 | 0.120 |
Why?
|
| Metabolism | 2 | 2005 | 43 | 0.120 |
Why?
|
| Alanine | 4 | 2023 | 181 | 0.120 |
Why?
|
| Peptide Fragments | 1 | 1999 | 745 | 0.120 |
Why?
|
| Child Development | 1 | 2017 | 250 | 0.120 |
Why?
|
| Cholestenones | 1 | 2014 | 7 | 0.120 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 503 | 0.120 |
Why?
|
| Sorbitol | 1 | 2014 | 6 | 0.120 |
Why?
|
| Permeability | 3 | 2018 | 118 | 0.110 |
Why?
|
| Dipeptides | 1 | 1994 | 56 | 0.110 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2014 | 41 | 0.110 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2017 | 184 | 0.110 |
Why?
|
| Mothers | 1 | 2017 | 348 | 0.110 |
Why?
|
| Immunohistochemistry | 5 | 2012 | 1717 | 0.110 |
Why?
|
| Ampicillin | 1 | 2013 | 58 | 0.110 |
Why?
|
| Cell Count | 2 | 2004 | 253 | 0.110 |
Why?
|
| Animals, Inbred Strains | 1 | 2013 | 5 | 0.110 |
Why?
|
| Gastroenteritis | 1 | 2016 | 333 | 0.110 |
Why?
|
| Reference Values | 4 | 2014 | 699 | 0.110 |
Why?
|
| Immunity, Mucosal | 1 | 2013 | 83 | 0.110 |
Why?
|
| Lysine | 4 | 2003 | 200 | 0.110 |
Why?
|
| Treatment Outcome | 6 | 2019 | 12083 | 0.110 |
Why?
|
| Nitric Oxide Synthase | 2 | 2004 | 186 | 0.110 |
Why?
|
| Obesity | 2 | 2024 | 2092 | 0.110 |
Why?
|
| Caliciviridae Infections | 1 | 2016 | 315 | 0.110 |
Why?
|
| Gentamicins | 1 | 2013 | 95 | 0.110 |
Why?
|
| Transcriptome | 1 | 2019 | 909 | 0.110 |
Why?
|
| Caprylates | 1 | 2013 | 12 | 0.110 |
Why?
|
| Enteroendocrine Cells | 2 | 2019 | 20 | 0.110 |
Why?
|
| Infant, Low Birth Weight | 1 | 2014 | 164 | 0.110 |
Why?
|
| RNA | 6 | 1997 | 577 | 0.110 |
Why?
|
| Metronidazole | 1 | 2013 | 155 | 0.110 |
Why?
|
| Drug Combinations | 1 | 2014 | 267 | 0.110 |
Why?
|
| Catheterization | 3 | 2008 | 238 | 0.110 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2014 | 144 | 0.100 |
Why?
|
| Ornithine | 1 | 2012 | 25 | 0.100 |
Why?
|
| Biosynthetic Pathways | 1 | 2012 | 24 | 0.100 |
Why?
|
| Congresses as Topic | 1 | 2014 | 164 | 0.100 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2013 | 90 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 1034 | 0.100 |
Why?
|
| Sepsis | 1 | 2017 | 479 | 0.100 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 50 | 0.100 |
Why?
|
| Endpoint Determination | 1 | 2012 | 52 | 0.100 |
Why?
|
| Nucleic Acids | 1 | 1992 | 23 | 0.100 |
Why?
|
| Liver Circulation | 3 | 2003 | 24 | 0.100 |
Why?
|
| Myocardium | 1 | 1997 | 983 | 0.100 |
Why?
|
| Incretins | 1 | 2012 | 25 | 0.100 |
Why?
|
| Chenodeoxycholic Acid | 1 | 2011 | 14 | 0.100 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 469 | 0.100 |
Why?
|
| Administration, Intravenous | 1 | 2012 | 143 | 0.100 |
Why?
|
| Pyridoxal Phosphate | 1 | 2011 | 13 | 0.100 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2011 | 15 | 0.100 |
Why?
|
| Methylmalonic Acid | 1 | 2011 | 14 | 0.100 |
Why?
|
| Metagenome | 1 | 2012 | 150 | 0.100 |
Why?
|
| Microarray Analysis | 1 | 2012 | 231 | 0.100 |
Why?
|
| Asthma | 1 | 2019 | 746 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 342 | 0.090 |
Why?
|
| Energy Intake | 2 | 2010 | 450 | 0.090 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2021 | 99 | 0.090 |
Why?
|
| Glutamates | 1 | 1991 | 69 | 0.090 |
Why?
|
| Peptide YY | 2 | 2001 | 17 | 0.090 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2010 | 59 | 0.090 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2010 | 20 | 0.090 |
Why?
|
| Weaning | 3 | 2019 | 40 | 0.090 |
Why?
|
| Enterocytes | 2 | 2016 | 70 | 0.090 |
Why?
|
| Pregnancy, Animal | 2 | 2011 | 74 | 0.090 |
Why?
|
| Isotopes | 1 | 2009 | 26 | 0.090 |
Why?
|
| Interleukin-10 | 1 | 2011 | 172 | 0.090 |
Why?
|
| Nutritive Value | 2 | 2020 | 91 | 0.080 |
Why?
|
| Fasting | 5 | 2002 | 299 | 0.080 |
Why?
|
| Glucagon | 2 | 2017 | 187 | 0.080 |
Why?
|
| Lung | 1 | 1997 | 1484 | 0.080 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2009 | 4 | 0.080 |
Why?
|
| Nitrogen Isotopes | 1 | 2009 | 54 | 0.080 |
Why?
|
| Iodine Radioisotopes | 1 | 2009 | 75 | 0.080 |
Why?
|
| Rats, Inbred Strains | 5 | 1992 | 229 | 0.080 |
Why?
|
| Child | 5 | 2021 | 24170 | 0.080 |
Why?
|
| Dysbiosis | 2 | 2020 | 120 | 0.080 |
Why?
|
| Starvation | 1 | 1988 | 15 | 0.080 |
Why?
|
| Gastric Inhibitory Polypeptide | 2 | 2015 | 19 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 1006 | 0.080 |
Why?
|
| Goblet Cells | 1 | 2009 | 101 | 0.080 |
Why?
|
| Tissue Distribution | 2 | 2005 | 382 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2006 | 174 | 0.070 |
Why?
|
| Postprandial Period | 2 | 2004 | 75 | 0.070 |
Why?
|
| Caspases | 2 | 2006 | 160 | 0.070 |
Why?
|
| Sulfur Compounds | 1 | 2007 | 4 | 0.070 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2007 | 14 | 0.070 |
Why?
|
| S-Adenosylmethionine | 1 | 2007 | 30 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2541 | 0.070 |
Why?
|
| Dogs | 3 | 2003 | 770 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 1834 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 94 | 0.070 |
Why?
|
| Protein Deficiency | 2 | 1996 | 20 | 0.070 |
Why?
|
| Transcription, Genetic | 3 | 2001 | 1703 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 111 | 0.070 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2006 | 20 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 424 | 0.070 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2005 | 8 | 0.060 |
Why?
|
| DNA Primers | 1 | 2007 | 669 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2017 | 3002 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 2846 | 0.060 |
Why?
|
| Algorithms | 3 | 2009 | 1583 | 0.060 |
Why?
|
| Mesenteric Arteries | 1 | 2006 | 57 | 0.060 |
Why?
|
| Fetal Growth Retardation | 2 | 1997 | 222 | 0.060 |
Why?
|
| Blood Flow Velocity | 2 | 2011 | 448 | 0.060 |
Why?
|
| Cell Line | 1 | 2010 | 2787 | 0.060 |
Why?
|
| Caspase 6 | 1 | 2004 | 4 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2019 | 339 | 0.060 |
Why?
|
| Caspase Inhibitors | 1 | 2004 | 29 | 0.060 |
Why?
|
| Critical Illness | 1 | 2009 | 594 | 0.060 |
Why?
|
| Mass Spectrometry | 3 | 2019 | 324 | 0.060 |
Why?
|
| Texas | 1 | 2013 | 3542 | 0.060 |
Why?
|
| CD13 Antigens | 2 | 2001 | 15 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 2006 | 3888 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2004 | 131 | 0.060 |
Why?
|
| Glutamate Plasma Membrane Transport Proteins | 1 | 2004 | 4 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2013 | 2396 | 0.060 |
Why?
|
| Gastrins | 2 | 2002 | 32 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 762 | 0.060 |
Why?
|
| Jejunostomy | 2 | 2014 | 20 | 0.060 |
Why?
|
| Hormones | 2 | 2002 | 189 | 0.060 |
Why?
|
| Claudin-1 | 1 | 2003 | 18 | 0.060 |
Why?
|
| Stem Cells | 2 | 2021 | 713 | 0.060 |
Why?
|
| Osmolar Concentration | 2 | 2001 | 173 | 0.060 |
Why?
|
| Pancreatic Hormones | 1 | 2003 | 4 | 0.060 |
Why?
|
| Tight Junctions | 1 | 2003 | 37 | 0.060 |
Why?
|
| Bacterial Translocation | 1 | 2003 | 24 | 0.060 |
Why?
|
| Diuresis | 1 | 2003 | 58 | 0.050 |
Why?
|
| Sequence Homology | 1 | 2003 | 63 | 0.050 |
Why?
|
| Rodentia | 1 | 2003 | 46 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 2013 | 1404 | 0.050 |
Why?
|
| Enteritis | 1 | 2003 | 55 | 0.050 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2002 | 39 | 0.050 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2002 | 61 | 0.050 |
Why?
|
| Jugular Veins | 1 | 2002 | 75 | 0.050 |
Why?
|
| Chickens | 1 | 2003 | 637 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 2443 | 0.050 |
Why?
|
| Gastrointestinal Motility | 1 | 2002 | 45 | 0.050 |
Why?
|
| Age Factors | 3 | 2020 | 2799 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2003 | 2702 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2002 | 55 | 0.050 |
Why?
|
| Bile Ducts | 1 | 2022 | 64 | 0.050 |
Why?
|
| Neuroglia | 1 | 2004 | 193 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 3 | 2012 | 1598 | 0.050 |
Why?
|
| Diet, Western | 1 | 2021 | 17 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2004 | 460 | 0.050 |
Why?
|
| Deuterium | 3 | 1997 | 103 | 0.050 |
Why?
|
| Carotid Arteries | 1 | 2002 | 151 | 0.050 |
Why?
|
| Growth and Development | 1 | 2021 | 22 | 0.050 |
Why?
|
| Organ Specificity | 2 | 2004 | 428 | 0.050 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 40 | 0.050 |
Why?
|
| Nucleotides | 1 | 2002 | 92 | 0.050 |
Why?
|
| Rumen | 2 | 2010 | 8 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2002 | 141 | 0.050 |
Why?
|
| Hindlimb | 3 | 2008 | 75 | 0.050 |
Why?
|
| Cerebellum | 2 | 2023 | 414 | 0.050 |
Why?
|
| Scintillation Counting | 1 | 2001 | 6 | 0.050 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 33 | 0.050 |
Why?
|
| Tyrosine | 3 | 2008 | 166 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 558 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2001 | 198 | 0.050 |
Why?
|
| Histocytochemistry | 1 | 2001 | 106 | 0.050 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2000 | 23 | 0.050 |
Why?
|
| Alkaline Phosphatase | 1 | 2001 | 96 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 123 | 0.050 |
Why?
|
| Poly A | 1 | 2000 | 59 | 0.050 |
Why?
|
| RNA, Ribosomal | 1 | 2000 | 58 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2000 | 77 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2004 | 677 | 0.040 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2001 | 98 | 0.040 |
Why?
|
| Culture Media | 1 | 2021 | 183 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2007 | 993 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 415 | 0.040 |
Why?
|
| Frontal Lobe | 1 | 2020 | 111 | 0.040 |
Why?
|
| Basement Membrane | 1 | 2000 | 46 | 0.040 |
Why?
|
| Ribosomes | 1 | 2000 | 138 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2001 | 210 | 0.040 |
Why?
|
| Radioisotope Dilution Technique | 2 | 1997 | 43 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2001 | 304 | 0.040 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2000 | 196 | 0.040 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2019 | 14 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2020 | 215 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 2020 | 189 | 0.040 |
Why?
|
| Receptors, Somatomedin | 1 | 1999 | 25 | 0.040 |
Why?
|
| Survival Rate | 1 | 2004 | 1999 | 0.040 |
Why?
|
| Sermorelin | 1 | 1998 | 2 | 0.040 |
Why?
|
| Receptors, Pituitary Hormone-Regulating Hormone | 1 | 1998 | 3 | 0.040 |
Why?
|
| Receptors, Neuropeptide | 1 | 1998 | 9 | 0.040 |
Why?
|
| Blood Urea Nitrogen | 2 | 2000 | 70 | 0.040 |
Why?
|
| Autoradiography | 1 | 1998 | 71 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2021 | 679 | 0.040 |
Why?
|
| Biological Transport | 1 | 2019 | 347 | 0.040 |
Why?
|
| Fetal Death | 1 | 2019 | 115 | 0.040 |
Why?
|
| Protein Binding | 1 | 2022 | 1738 | 0.040 |
Why?
|
| Diet, Protein-Restricted | 2 | 1997 | 82 | 0.040 |
Why?
|
| Retinol-Binding Proteins | 2 | 1996 | 22 | 0.040 |
Why?
|
| Allografts | 1 | 2019 | 190 | 0.040 |
Why?
|
| Prealbumin | 2 | 1996 | 27 | 0.040 |
Why?
|
| Biopsy, Needle | 2 | 2011 | 232 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2001 | 576 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 176 | 0.040 |
Why?
|
| Shrews | 1 | 2017 | 5 | 0.040 |
Why?
|
| Birth Weight | 1 | 2019 | 334 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2002 | 946 | 0.040 |
Why?
|
| alpha-Tocopherol | 2 | 2008 | 37 | 0.040 |
Why?
|
| Lactation | 1 | 1999 | 186 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 1998 | 193 | 0.040 |
Why?
|
| Serum Albumin | 4 | 2001 | 110 | 0.040 |
Why?
|
| Radioactive Tracers | 2 | 2012 | 20 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2021 | 13858 | 0.040 |
Why?
|
| Cell Movement | 1 | 2001 | 838 | 0.040 |
Why?
|
| Ligands | 1 | 1998 | 535 | 0.040 |
Why?
|
| Arteries | 2 | 1999 | 222 | 0.040 |
Why?
|
| Interleukins | 1 | 2018 | 116 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2020 | 477 | 0.040 |
Why?
|
| Motor Activity | 1 | 2020 | 514 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2019 | 395 | 0.040 |
Why?
|
| Carbon | 1 | 1997 | 88 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2017 | 103 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 2025 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 2019 | 210 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2017 | 203 | 0.030 |
Why?
|
| Aminopeptidases | 2 | 2009 | 19 | 0.030 |
Why?
|
| Bile | 1 | 2016 | 47 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2019 | 405 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 317 | 0.030 |
Why?
|
| Cholesterol | 1 | 2019 | 522 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 2016 | 86 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2003 | 1529 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 1996 | 137 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2019 | 554 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 288 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2017 | 6020 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 756 | 0.030 |
Why?
|
| Cognition | 1 | 2020 | 734 | 0.030 |
Why?
|
| Computational Biology | 1 | 2019 | 794 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 664 | 0.030 |
Why?
|
| Pulsatile Flow | 1 | 2014 | 133 | 0.030 |
Why?
|
| Ammonia | 1 | 1994 | 68 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 2 | 2004 | 142 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2001 | 1936 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 1994 | 410 | 0.030 |
Why?
|
| Adolescent | 3 | 2019 | 19043 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 1380 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2013 | 95 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2013 | 317 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2012 | 142 | 0.030 |
Why?
|
| Mucins | 1 | 2012 | 74 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1680 | 0.030 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2013 | 117 | 0.030 |
Why?
|
| Hepatic Veins | 1 | 2012 | 23 | 0.030 |
Why?
|
| Bifidobacterium | 1 | 2012 | 63 | 0.030 |
Why?
|
| Adenosine Triphosphate | 2 | 2006 | 288 | 0.020 |
Why?
|
| Fibrinogen | 3 | 1998 | 152 | 0.020 |
Why?
|
| Litter Size | 1 | 1991 | 25 | 0.020 |
Why?
|
| Mesentery | 1 | 2011 | 28 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 516 | 0.020 |
Why?
|
| DNA Replication | 1 | 2013 | 345 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 371 | 0.020 |
Why?
|
| Stomach, Ruminant | 1 | 2010 | 1 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 1990 | 63 | 0.020 |
Why?
|
| Glucose Clamp Technique | 2 | 2002 | 78 | 0.020 |
Why?
|
| Thyroxine | 1 | 1990 | 65 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2011 | 148 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2009 | 156 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2824 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 2104 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2009 | 143 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 25885 | 0.020 |
Why?
|
| Ischemia | 1 | 2011 | 344 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 4688 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 28944 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 3257 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2006 | 51 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2006 | 38 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2006 | 53 | 0.020 |
Why?
|
| fas Receptor | 1 | 2006 | 43 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2006 | 70 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2006 | 76 | 0.020 |
Why?
|
| Cytosol | 1 | 2006 | 160 | 0.020 |
Why?
|
| Mannitol | 1 | 2006 | 48 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2006 | 89 | 0.020 |
Why?
|
| Causality | 1 | 2006 | 78 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2006 | 155 | 0.020 |
Why?
|
| Precipitin Tests | 2 | 1996 | 153 | 0.020 |
Why?
|
| Bilirubin | 1 | 2006 | 129 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2006 | 142 | 0.020 |
Why?
|
| Retinol-Binding Proteins, Plasma | 2 | 1996 | 15 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2011 | 983 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1996 | 314 | 0.020 |
Why?
|
| Probability | 1 | 2006 | 319 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2006 | 213 | 0.020 |
Why?
|
| Hydroxylation | 1 | 2005 | 45 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2013 | 3782 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2006 | 481 | 0.010 |
Why?
|
| Consciousness | 1 | 2004 | 49 | 0.010 |
Why?
|
| Antioxidants | 1 | 2006 | 341 | 0.010 |
Why?
|
| Hepatic Artery | 1 | 2003 | 52 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 8830 | 0.010 |
Why?
|
| Absorption | 1 | 2002 | 52 | 0.010 |
Why?
|
| Motilin | 1 | 2002 | 2 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2004 | 359 | 0.010 |
Why?
|
| Manometry | 1 | 2002 | 48 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2002 | 146 | 0.010 |
Why?
|
| Glutamyl Aminopeptidase | 1 | 2001 | 3 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 1 | 2001 | 48 | 0.010 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2001 | 8 | 0.010 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2001 | 7 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 3118 | 0.010 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2001 | 18 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2002 | 252 | 0.010 |
Why?
|
| Receptors, Somatotropin | 1 | 2000 | 9 | 0.010 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2000 | 44 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2004 | 1164 | 0.010 |
Why?
|
| Lactates | 1 | 1999 | 93 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1998 | 71 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1998 | 160 | 0.010 |
Why?
|
| Mathematics | 1 | 1998 | 98 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 1998 | 67 | 0.010 |
Why?
|
| Albumins | 1 | 1998 | 90 | 0.010 |
Why?
|
| Body Fluid Compartments | 1 | 1998 | 18 | 0.010 |
Why?
|
| Eukaryotic Initiation Factor-1 | 1 | 1998 | 4 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1998 | 77 | 0.010 |
Why?
|
| Dimerization | 1 | 1998 | 144 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 1997 | 40 | 0.010 |
Why?
|
| Citric Acid Cycle | 1 | 1997 | 44 | 0.010 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1997 | 52 | 0.010 |
Why?
|
| Peptide Biosynthesis | 1 | 1996 | 19 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1997 | 260 | 0.010 |
Why?
|
| Glycoside Hydrolases | 1 | 1996 | 17 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1996 | 55 | 0.010 |
Why?
|
| Gluconeogenesis | 1 | 1997 | 107 | 0.010 |
Why?
|
| Haptoglobins | 1 | 1996 | 15 | 0.010 |
Why?
|
| Glycine | 1 | 1997 | 167 | 0.010 |
Why?
|
| Transferrin | 1 | 1996 | 51 | 0.010 |
Why?
|
| Apolipoprotein A-I | 1 | 1996 | 79 | 0.010 |
Why?
|
| Mammals | 1 | 1997 | 263 | 0.010 |
Why?
|
| Water | 1 | 1996 | 181 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1996 | 122 | 0.010 |
Why?
|
| Muscular Atrophy | 1 | 1996 | 75 | 0.010 |
Why?
|
| Edema | 1 | 1996 | 134 | 0.010 |
Why?
|
| Apolipoprotein B-100 | 1 | 1994 | 33 | 0.010 |
Why?
|
| Apolipoproteins B | 1 | 1994 | 131 | 0.010 |
Why?
|
| Bone Density | 1 | 1996 | 309 | 0.010 |
Why?
|
| Skin | 1 | 1996 | 506 | 0.010 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 1991 | 26 | 0.010 |
Why?
|
| Hydroxybutyrates | 1 | 1991 | 44 | 0.010 |
Why?
|
| United States | 1 | 2004 | 10564 | 0.010 |
Why?
|